Submitted by Anonymous (not verified) on 27 November 2023 - 13:00
Human medicines European public assessment report (EPAR): Apexxnar, pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed), Pneumococcal Infections, Date of authorisation: 14/02/2022, Revision: 6, Status: Authorised
Source: